Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$276M |
| 2 |
Procter & Gamble
PG
|
+$243M |
| 3 |
Analog Devices
ADI
|
+$188M |
| 4 |
Advanced Micro Devices
AMD
|
+$171M |
| 5 |
Home Depot
HD
|
+$162M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.95B |
| 2 |
Bristol-Myers Squibb
BMY
|
+$778M |
| 3 |
Walmart Inc
WMT
|
+$723M |
| 4 |
Zoom
ZM
|
+$642M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$573M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.93% |
| 2 | Technology | 16.65% |
| 3 | Consumer Staples | 12.19% |
| 4 | Consumer Discretionary | 9.52% |
| 5 | Communication Services | 9.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2726
LiveOne
LVO
$61.7M
| $646K | ﹤0.01% |
24,890
-100
| -0.4% | -$3.13K |
|
2727
Vanguard Russell 1000 Growth ETF
VONG
$42.8B
| $646K | ﹤0.01% |
11,600
-7,600
| -40% | -$412K |
|
2728
iShares Europe ETF
IEV
$1.67B
| $645K | ﹤0.01% |
+15,400
| New | +$658K |
|
|
QVCGA
2729
DELISTED
QVC Group Inc Series A
QVCGA
| $642K | ﹤0.01% |
1,789
-24,568
| -93% | -$11.6M |
|
|
EIDX
2730
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
| $642K | ﹤0.01% |
12,701
-46,300
| -78% | -$2.08M |
|
2731
FlexShares Global Upstream Natural Resources Index Fund
GUNR
$7.2B
| $641K | ﹤0.01% |
+23,100
| New | +$673K |
|
2732
Emerson Radio
MSN
$7.79M
| $639K | ﹤0.01% |
939,674
+31,324
| +3% | +$22K |
|
|
TREC
2733
DELISTED
Trecora Resources
TREC
| $637K | ﹤0.01% |
103,685
-23,064
| -18% | -$140K |
|
2734
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
$11.5B
| $636K | ﹤0.01% |
17,300
-111,400
| -87% | -$4.1M |
|
2735
Protara Therapeutics
TARA
$220M
| $636K | ﹤0.01% |
37,786
+7,800
| +26% | +$181K |
|
2736
Highway Holdings
HIHO
$4.07M
| $634K | ﹤0.01% |
228,027
+30,400
| +15% | +$84.8K |
|
|
EPIX
2737
DELISTED
ESSA Pharma
EPIX
| $633K | ﹤0.01% |
91,800
+54,023
| +143% | +$367K |
|
2738
Energy Focus
EFOI
$19.4M
| $631K | ﹤0.01% |
13,129
+4,789
| +57% | +$233K |
|
2739
Invesco Taxable Municipal Bond ETF
BAB
$1.02B
| $630K | ﹤0.01% |
18,900
-8,600
| -31% | -$287K |
|
2740
Gevo
GEVO
$360M
| $627K | ﹤0.01% |
627,600
+255,476
| +69% | +$205K |
|
2741
Comstock Resources
CRK
$3.89B
| $626K | ﹤0.01% |
142,885
+3,785
| +3% | +$20.1K |
|
|
AUTL
2742
Autolus Therapeutics
AUTL
$397M
| $625K | ﹤0.01% |
53,656
-18,744
| -26% | -$272K |
|
2743
iShares MSCI Europe Financials ETF
EUFN
$4.14B
| $624K | ﹤0.01% |
+45,400
| New | +$672K |
|
|
XENT
2744
DELISTED
Intersect ENT, Inc
XENT
| $623K | ﹤0.01% |
38,200
-29,300
| -43% | -$531K |
|
2745
Equillium
EQ
$139M
| $619K | ﹤0.01% |
107,349
+7,200
| +7% | +$58.3K |
|
|
ALTR
2746
DELISTED
Altair Engineering Inc
ALTR
| $613K | ﹤0.01% |
+14,600
| New | +$587K |
|
2747
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$19.2B
| $612K | ﹤0.01% |
3,400
-4,200
| -55% | -$741K |
|
|
DLA
2748
DELISTED
Delta Apparel Inc.
DLA
| $610K | ﹤0.01% |
42,800
+23,200
| +118% | +$321K |
|
|
UMH
2749
UMH Properties
UMH
$1.29B
| $608K | ﹤0.01% |
+44,900
| New | +$599K |
|
2750
Ascent Industries
ACNT
$140M
| $607K | ﹤0.01% |
110,000
-18,300
| -14% | -$124K |
|
Similar funds
Renaissance Technologies's Q3 2020 Portfolio in Review
As of Q3 2020, Renaissance Technologies held 3,879 positions worth $100B, down 14% from $116B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Renaissance Technologies withdrew a net $21.7B in Q3 2020, closing 544 positions and reducing 1,671 holdings. Its most notable exit was Alibaba, an estimated $426M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 23% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Renaissance Technologies opened a new position in Microsoft worth $277M.
- Renaissance Technologies's largest Q3 2020 buy was Microsoft: 1,315,812 shares worth $277M.
- Renaissance Technologies added most to Procter & Gamble in Q3 2020, an estimated $243M increase.
- Renaissance Technologies's biggest Q3 2020 reduction was Tesla, cutting an estimated $1.95B.
- Renaissance Technologies fully exited Alibaba in Q3 2020, selling an estimated $426M.
- Renaissance Technologies's ten largest holdings make up 15% of its $100B portfolio in Q3 2020.
- Renaissance Technologies opened 490 new positions and closed 544 in Q3 2020.
- Renaissance Technologies's portfolio value fell 14% quarter-over-quarter to $100B.
Based on Renaissance Technologies's 13F filing for Q3 2020, filed 13 Nov 2020.